2024 Journal Article Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 monthsHaworth, Charles S, Shteinberg, Michal, Winthrop, Kevin, Barker, Alan, Blasi, Francesco, Dimakou, Katerina, Morgan, Lucy C, O'Donnell, Anne E, Ringshausen, Felix C, Sibila, Oriol, Thomson, Rachel M, Carroll, Kevin J, Pontenani, Federica, Castellani, Paola and Chalmers, James D (2024). Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 months. The Lancet Respiratory Medicine, 12 (10), 787-798. doi: 10.1016/s2213-2600(24)00225-x |
2024 Journal Article Current physiotherapy practice for adults with bronchiectasis: data from the Australian Bronchiectasis RegistryWebb, Elizabeth M., Holland, Anne E., Chang, Anne B., Burr, Lucy, Holmes-Liew, Chien-Li, King, Paul T., Middleton, Peter G., Morgan, Lucy, Thomson, Rachel M., Wong, Conroy and Lee, Annemarie L. (2024). Current physiotherapy practice for adults with bronchiectasis: data from the Australian Bronchiectasis Registry. Respiratory Medicine, 233 107777, 107777. doi: 10.1016/j.rmed.2024.107777 |
2024 Conference Publication Developing a pharmacovigilance framework for an investigator-led, non-commercial platform trial – finding the optimal regimen for Mycobacterium abscessus treatment (FORMaT)Hicks, D., Jong, T., Rice, M., Gailer, N., Joshi, S., Stevens, L., Lee, K., Thomson, R., Burke, A., Grimwood, K., Bell, S., Clark, J. and Wainwright, C.E. (2024). Developing a pharmacovigilance framework for an investigator-led, non-commercial platform trial – finding the optimal regimen for Mycobacterium abscessus treatment (FORMaT). 47th European Cystic Fibrosis Conference, Glasgow, United Kingdom, 5-8 June 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s1569-1993(24)00244-3 |
2024 Conference Publication Validation of the BACES Severity Scoring System in an Australian Cohort of Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) Patients Mishiro, K., Ballard, E., Goh, F. and Thomson, R. (2024). Validation of the BACES Severity Scoring System in an Australian Cohort of Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) Patients . American Thoracic Society International Conference 2024, San Diego, CA United States, 17-22 May 2024. New York, NY United States: American Thoracic Society. doi: 10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a3158 |
2024 Journal Article OPTIMA: an open-label, non-comparative pilot trial of inhaled molgramostim in pulmonary nontuberculous mycobacterial infectionThomson, Rachel M., Loebinger, Michael R., Burke, Andrew J., Morgan, Lucy C., Waterer, Grant W. and Ganslandt, Cecilia (2024). OPTIMA: an open-label, non-comparative pilot trial of inhaled molgramostim in pulmonary nontuberculous mycobacterial infection. Annals of the American Thoracic Society, 21 (4), 568-576. doi: 10.1513/annalsats.202306-532oc |
2023 Journal Article Things They Are a Changing in the Field of Nontuberculous MycobacteriaKasperbauer, Shannon and Thomson, Rachel (2023). Things They Are a Changing in the Field of Nontuberculous Mycobacteria. Clinics in Chest Medicine, 44 (4), xiii-xiv. doi: 10.1016/j.ccm.2023.09.001 |
2023 Journal Article Extended water stagnation in buildings during the COVID-19 pandemic increases the risks posed by opportunistic pathogensHuang, Casey K., Weerasekara, Anjani, Lu, Ji, Carter, Robyn, Weynberg, Karen D., Thomson, Rachel, Bell, Scott and Guo, Jianhua (2023). Extended water stagnation in buildings during the COVID-19 pandemic increases the risks posed by opportunistic pathogens. Water Research: X, 21 100201, 100201. doi: 10.1016/j.wroa.2023.100201 |
2023 Journal Article In vitro susceptibility testing of imipenem- relebactam and tedizolid against 102 Mycobacterium abscessus isolatesBurke, Andrew, Carter, Robyn, Tolson, Carla, Congdon, Jacob, Duplancic, Christine, Bursle, Evan, Bell, Scott C., Roberts, Jason A. and Thomson, Rachel (2023). In vitro susceptibility testing of imipenem- relebactam and tedizolid against 102 Mycobacterium abscessus isolates. International Journal of Antimicrobial Agents, 62 (4) 106938, 1-6. doi: 10.1016/j.ijantimicag.2023.106938 |
2023 Journal Article A systematic review of the clinical impact of small colony variants in patients with cystic fibrosisRyan, Harrigan, Ballard, Emma, Stockwell, Rebecca E., Duplancic, Christine, Thomson, Rachel M., Smith, Kimberley and Bell, Scott C. (2023). A systematic review of the clinical impact of small colony variants in patients with cystic fibrosis. BMC Pulmonary Medicine, 23 (1) 323, 1-10. doi: 10.1186/s12890-023-02611-4 |
2023 Conference Publication A method for the isolation of environmental Mycobacterium species from soil and house dustCarter, R. M., Huygens, F. and Thomson, R. (2023). A method for the isolation of environmental Mycobacterium species from soil and house dust. International Conference of the American Thoracic Society (ATS) 2023, Washington, DC, United States, 19 - 24 May 2023. New York, NY, United States: American Thoracic Society. doi: 10.1164/ajrccm-conference.2023.207.1_MeetingAbstracts.A3594 |
2023 Conference Publication In vitro susceptibility testing of imipenem- relebactam and tedizolid against australian mycobacterium abscessus isolatesBurke, A. J., Carter, R., Tolson, C., Congdon, J., Duplancic, C., Bursle, E., Bell, S., Roberts, J. and Thomson, R. (2023). In vitro susceptibility testing of imipenem- relebactam and tedizolid against australian mycobacterium abscessus isolates. ATS 2023 International Conference, Washington, DC USA, 19-24 May 2023. Washington, DC USA: American Thoracic Society. doi: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a2968 |
2023 Conference Publication Evolution of antimicrobial resistance in Mycobacterium abscessus isolated from drinking waterPatterson-Fahy, K., Carter, R., Guo, J. and Thomson, R. (2023). Evolution of antimicrobial resistance in Mycobacterium abscessus isolated from drinking water. International Conference of the American Thoracic Society (ATS) 2023, Washington, DC, United States, 19 - 24 May 2023. New York, NY, United States: American Thoracic Society. doi: 10.1164/ajrccm-conference.2023.207.1_MeetingAbstracts.A2952 |
2023 Journal Article Environmental risk of nontuberculous mycobacterial infection: strategies for advancing methodologyMercaldo, Rachel A., Marshall, Julia E., Cangelosi, Gerard A., Donohue, Maura, Falkinham, Joseph O., Fierer, Noah, French, Joshua P., Gebert, Matthew J., Honda, Jennifer R., Lipner, Ettie M., Marras, Theodore K., Morimoto, Kozo, Salfinger, Max, Stout, Janet, Thomson, Rachel and Prevots, D. Rebecca (2023). Environmental risk of nontuberculous mycobacterial infection: strategies for advancing methodology. Tuberculosis, 139 102305, 102305. doi: 10.1016/j.tube.2023.102305 |
2023 Conference Publication Nontuberculous mycobacteria in Australians with cystic fibrosis: A national surveyBell, S., Duplancic, C., Wainwright, C., Thomson, R., Rogers, G., Clements, A. and Floto, R. (2023). Nontuberculous mycobacteria in Australians with cystic fibrosis: A national survey. TSANZSRS 2023 Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science, Christchurch, New Zealand, 25 - 28 March 2023. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/resp.14459 |
2023 Conference Publication Distribution and diversity of respiratory and non-respiratory Mycobacterium abscessus infectionsSmith, K., Taylor, S., Zheng, L., Rogers, G., Coulter, C., Pandey, S., Thomson, R. and Bell, S. (2023). Distribution and diversity of respiratory and non-respiratory Mycobacterium abscessus infections. TSANZSRS 2023 The Australia and New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health and Respiratory Science, Christchurch, New Zealand, 25–28 March 2023. Richmond, VIC Australia: John Wiley and Sons. doi: 10.1111/resp.14459 |
2023 Conference Publication Validation of cromolyn sodium as a marker of aspirationRiddles, T., Semple, K. and Thomson, R. (2023). Validation of cromolyn sodium as a marker of aspiration. TSANZSRS 2023 (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science, Christchurch, New Zealand, 25 - 28 March 2023. Richmond, VIC, Australia: John Wiley & Sons. |
2023 Conference Publication Mycobacterium abscessus: Acquisition and transmission pathwaysRamsay, K., Smith, K., Carter, R., Clayton, M., Burke, A., Wainwright, C., Thomson, R. and Bell, S. (2023). Mycobacterium abscessus: Acquisition and transmission pathways. TSANZSRS 2023 The Australia and New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health and Respiratory Science, Christchurch, New Zealand, 25–28 March 2023. Richmond, VIC Australia: John Wiley and Sons. doi: 10.1111/resp.14459 |
2023 Journal Article Nontuberculous Mycobacteria in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Regulator ModulatorsBurke, Andrew, Thomson, Rachel M., Wainwright, Claire E. and Bell, Scott C. (2023). Nontuberculous Mycobacteria in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Regulator Modulators. Seminars in Respiratory and Critical Care Medicine, 44 (02), 287-296. doi: 10.1055/s-0042-1759883 |
2023 Journal Article ‘Teach me how to look after myself’: what people with bronchiectasis want from education in a pulmonary rehabilitation settingLee, Annemarie L., Smith, Rebecca, Burr, Lucy, Chang, Anne B., Holmes‐Liew, Chien‐Li, King, Paul, Middleton, Peter, Morgan, Lucy, Smith, Daniel, Thomson, Rachel, Waterer, Grant, Wong, Conroy and McAleer, Rachael (2023). ‘Teach me how to look after myself’: what people with bronchiectasis want from education in a pulmonary rehabilitation setting. The Clinical Respiratory Journal, 17 (1), 59-69. doi: 10.1111/crj.13563 |
2022 Journal Article Characterizing and correcting immune dysfunction in non-tuberculous mycobacterial diseaseRatnatunga, Champa N., Tungatt, Katie, Proietti, Carla, Halstrom, Sam, Holt, Michael R., Lutzky, Viviana P., Price, Patricia, Doolan, Denise L., Bell, Scott C., Field, Matt A., Kupz, Andreas, Thomson, Rachel M. and Miles, John J. (2022). Characterizing and correcting immune dysfunction in non-tuberculous mycobacterial disease. Frontiers in Immunology, 13 1047781, 1-20. doi: 10.3389/fimmu.2022.1047781 |